COST given budget boost for FP7

COST, the European Cooperation in Science and Technology, will continue to be managed by the European Science Foundation (ESF) under the Seventh Framework Programme (FP7). The European Commission and ESF signed a contract to this effect at the end of July.

Under the Sixth Framework Programme (FP6), EU support for COST amounted to €80 million, a figure which is set to rise to €210 million under FP7. An additional €40 million could be added to the pot if a mid-term evaluation in 2010 is successful.

"The contract and the increase in funding is indeed a strong vote of confidence towards the ESF-COST cooperation," said Dr Martin Grabert, Director of the COST Office. "With this contract, we can truly capitalise on previous successes. We will not rest on our laurels, however, and continue to focus on cross-disciplinary initiatives and strengthening the synergy between the various research actors in Europe."

The bigger budget will allow COST to expand its activities and boost support for both the scientific and technical committees and the COST Actions (networks of researchers).

The contract sets out a series of work packages which reflect the increase in funding through new and expanded activities, the development of new ideas for interdisciplinary science initiatives and a greater exploitation of the European 'Near Neighbours' policy. There is also a stronger focus on outreach and communications.

"The negotiation of this contract and the transition between FP6 and FP7 were two challenging processes," commented David Weber, the ESF's Director of Administration and Finance, noting that the ESF's commitment to COST, coupled with its experience of managing such a complex operation, had been key to the successful completion of the agreement.

"I very much welcome the positive conclusion of the negotiations for the signature of the EC-ESF contract for COST," added Professor Francesco Fedi, President of the COST Committee of Senior Officials. "COST has always been a unique instrument with a strong role to play towards the development of the ERA. Typical COST features such as its flexibility and bottom-up approach make it a perfect platform for innovative ideas on the frontiers of science."

A recent independent review of the Commission-ESF COST contract for FP6 noted the high levels of satisfaction among users of COST and concluded that the switchover from the COST Action managed by the European to the COST Office run by the ESF had been largely successful.

Established in 1971, COST is now used by researchers in 35 European countries to cooperate in common research projects supported by national funds.

For more information, please visit:

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...

AI Detects Hidden Heart Disease Using Ex…

Mass General Brigham researchers have developed a new AI tool in collaboration with the United States Department of Veterans Affairs (VA) to probe through previously collected CT scans and identify...

AI Medical Receptionist Modernizing Doct…

A virtual medical receptionist named "Cassie," developed through research at Texas A&M University, is transforming the way patients interact with health care providers. Cassie is a digital-human assistant created by Humanate...

AI Tool Set to Transform Characterisatio…

A multinational team of researchers, co-led by the Garvan Institute of Medical Research, has developed and tested a new AI tool to better characterise the diversity of individual cells within...

MHP-Net: A Revolutionary AI Model for Ac…

Liver cancer is the sixth most common cancer globally and a leading cause of cancer-related deaths. Accurate segmentation of liver tumors is a crucial step for the management of the...

Human-AI Collectives Make the Most Accur…

Diagnostic errors are among the most serious problems in everyday medical practice. AI systems - especially large language models (LLMs) like ChatGPT-4, Gemini, or Claude 3 - offer new ways...